pI: 8.6439 |
Length (AA): 176 |
MW (Da): 19423 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 165 | 3s4o (A) | 1 | 163 | 70.00 | 0 | 1 | 1.96174 | -2.42 |
98 | 148 | 2esb (A) | 89 | 138 | 34.00 | 0.08 | 0.29 | 0.593373 | 0.39 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128071)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV011660 | tyrosine phosphatase, putative |
Brugia malayi | Bm1_19115 | Dual specificity protein phosphatase CDC14B |
Caenorhabditis elegans | CELE_T19D2.2 | Protein PRL-1 |
Dictyostelium discoideum | DDB_G0292024 | hypothetical protein |
Drosophila melanogaster | Dmel_CG4993 | CG4993 gene product from transcript CG4993-RB |
Echinococcus granulosus | EgrG_000716100 | protein tyrosine phosphatase PRL |
Entamoeba histolytica | EHI_044560 | protein tyrosine phosphatase, putative |
Echinococcus multilocularis | EmuJ_000716100 | protein tyrosine phosphatase PRL |
Homo sapiens | ENSG00000112245 | protein tyrosine phosphatase type IVA, member 1 |
Homo sapiens | ENSG00000184007 | protein tyrosine phosphatase type IVA, member 2 |
Leishmania braziliensis | LbrM.16.0260 | protein tyrosine phosphatase-likie protein |
Leishmania braziliensis | LbrM.16.0240 | protein tyrosine phosphatase-like protein |
Leishmania donovani | LdBPK_160240.1 | protein tyrosine phosphatase-like protein |
Leishmania donovani | LdBPK_160260.1 | protein tyrosine phosphatase-likie protein |
Leishmania infantum | LinJ.16.0240 | protein tyrosine phosphatase-like protein |
Leishmania infantum | LinJ.16.0260 | protein tyrosine phosphatase-likie protein |
Leishmania major | LmjF.16.0230 | protein tyrosine phosphatase-like protein |
Leishmania major | LmjF.16.0250 | protein tyrosine phosphatase-likie protein |
Leishmania mexicana | LmxM.16.0250 | protein tyrosine phosphatase-likie protein |
Leishmania mexicana | LmxM.16.0230 | protein tyrosine phosphatase-like protein |
Loa Loa (eye worm) | LOAG_10083 | dual specificity protein phosphatase CDC14B |
Mus musculus | 100862124 | predicted gene 15026 |
Mus musculus | 102643131 | protein tyrosine phosphatase type IVA 1-like |
Mus musculus | 622019 | predicted gene 11780 |
Mus musculus | ENSMUSG00000059895 | protein tyrosine phosphatase 4a3 |
Mus musculus | ENSMUSG00000026064 | protein tyrosine phosphatase 4a1 |
Mus musculus | ENSMUSG00000028788 | protein tyrosine phosphatase 4a2 |
Neospora caninum | NCLIV_003240 | phosphatase, putative |
Plasmodium berghei | PBANKA_0934500 | protein tyrosine phosphatase |
Plasmodium falciparum | PF3D7_1113100 | protein tyrosine phosphatase |
Plasmodium knowlesi | PKNH_0910700 | protein tyrosine phosphatase, putative |
Plasmodium vivax | PVX_091305 | protein tyrosine phosphatase, putative |
Plasmodium yoelii | PY05564 | protein tyrosine phosphatase |
Schistosoma japonicum | Sjp_0035790 | Protein tyrosine phosphatase type IVA 3, putative |
Schistosoma japonicum | Sjp_0305570 | ko:K01104 protein-tyrosine phosphatase [EC3.1.3.48], putative |
Schistosoma japonicum | Sjp_0113010 | expressed protein |
Schistosoma mansoni | Smp_040550 | protein tyrosine phosphatase prl |
Schistosoma mansoni | Smp_005910 | protein tyrosine phosphatase prl |
Schmidtea mediterranea | mk4.000425.07 | |
Schmidtea mediterranea | mk4.001691.02 | |
Trypanosoma brucei gambiense | Tbg972.8.5790 | protein tyrosine phosphatase, putative |
Trypanosoma brucei | Tb927.8.5780 | phosphatase of regenerating liver-type phosphatase, putative |
Trypanosoma congolense | TcIL3000_8_5570 | protein tyrosine phosphatase, putative |
Trypanosoma cruzi | TcCLB.503471.10 | protein tyrosine phosphatase, putative |
Trypanosoma cruzi | TcCLB.510603.80 | protein tyrosine phosphatase-like protein, putative |
Trypanosoma cruzi | TcCLB.506743.130 | protein tyrosine phosphatase-like protein, putative |
Trypanosoma cruzi | TcCLB.503851.24 | protein tyrosine phosphatase PRL |
Trypanosoma cruzi | TcCLB.506743.110 | protein tyrosine phosphatase, putative |
Trypanosoma cruzi | TcCLB.509109.130 | protein tyrosine phosphatase-like protein, putative |
Trypanosoma cruzi | TcCLB.509109.120 | protein tyrosine phosphatase, putative |
Trypanosoma cruzi | TcCLB.510603.60 | protein tyrosine phosphatase-like protein, putative |
Toxoplasma gondii | TGME49_208722 | hypothetical protein |
Theileria parva | TP01_1140 | protein tyrosine phosphatase, putative |
Trichomonas vaginalis | TVAG_308020 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.5780 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.5780 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.5780 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.5780 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_208722 | Toxoplasma gondii | Probably essential | sidik |
TGME49_208722 | Toxoplasma gondii | Essentiality uncertain | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | protein tyrosine phosphatase type IVA, member 1 | Compounds | References |
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Tbru017497; Recombinant protein: full-length; Source: T brucei; protein tyrosine phosphatase, putative ; |
51 literature references were collected for this gene.